FDA Panel Reluctantly Backs Patisiran for ATTR Cardiomyopathy
FDA advisors conceded on Wednesday that the benefit-risk balance of patisiran (Onpattro) technically checks out in wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM, also known as cardiac ATTR amyloidosis) — though they were unconvinced that the benefits are actually meaningful. At the end of the day, the Cardiovascular and Renal Drugs Advisory Committee ultimately voted […]
When You Ignore My Gender, You Dehumanize Me
“What are you?” asks the medical assistant as he checks me in for my COVID-19 swab. As a medical student, I am routinely tested for COVID-19. “What do you mean?” My chest tightens, warning me of what’s to come. He looks exasperated, hands hovering over his keyboard. “Look. Are you a man or woman? I […]